Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease

NCT00191009 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: atomoxetine hydrochloride
DRUG: placebo

Sponsor

Eli Lilly and Company